SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Dave Nicholls, Jane Zochling, Anthony Boers, Gary Champion, David Mathers, John Riordan, Peter Youssef, James Scott, Hedley Griffiths, A retrospective chart review of the use of rituximab for the treatment of rheumatoid arthritis in Australian rheumatology practice, International Journal of Rheumatic Diseases, 2014, 17, 5
  2. 2
    J-O Pers, P Youinou, Are the B cells cast with the leading part in the Sjogren's syndrome scenario?, Oral Diseases, 2014, 20, 5
  3. 3
    M. Pertovaara, M. Korpela, ESSPRI and other patient-reported indices in patients with primary Sjogren's syndrome during 100 consecutive outpatient visits at one rheumatological clinic, Rheumatology, 2014, 53, 5, 927

    CrossRef

  4. 4
    G. F. Lehner, M. Brunner-Palka, T. Rettenbacher, R. Schmidauer, M. Herold, Maintenance of rituximab treatment in a patient with primary Sjogren's syndrome, Rheumatology, 2014, 53, 7, 1349

    CrossRef

  5. 5
    Raphaèle Seror, Elke Theander, Hendrika Bootsma, Simon J. Bowman, Athanasios Tzioufas, Jacques-Eric Gottenberg, Manel Ramos-Casals, Thomas Dörner, Philippe Ravaud, Xavier Mariette, Claudio Vitali, Outcome measures for primary Sjögren's syndrome: A comprehensive review, Journal of Autoimmunity, 2014, 51, 51

    CrossRef

  6. 6
    Divi Cornec, Christophe Jamin, Jacques-Olivier Pers, Sjögren's syndrome: Where do we stand, and where shall we go?, Journal of Autoimmunity, 2014, 51, 109

    CrossRef

  7. 7
    Orsia D. Konsta, Yosra Thabet, Christelle Le Dantec, Wesley H. Brooks, Athanasios G. Tzioufas, Jacques-Olivier Pers, Yves Renaudineau, The contribution of epigenetics in Sjögren’s Syndrome, Frontiers in Genetics, 2014, 5,

    CrossRef

  8. 8
    Gerwyn Morris, Michael Berk, Piotr Galecki, Michael Maes, The Emerging Role of Autoimmunity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/cfs), Molecular Neurobiology, 2014, 49, 2, 741

    CrossRef

  9. 9
    Sarah Brown, Nuria Navarro Coy, Costantino Pitzalis, Paul Emery, Sue Pavitt, Janine Gray, Claire Hulme, Frances Hall, Robert Busch, Pete Smith, Luke Dawson, Michele Bombardieri, Ng Wan-fai, Colin Pease, Elizabeth Price, Nurhan Sutcliffe, Clodagh Woods, Sharon Ruddock, Colin Everett, Catherine Reynolds, Emma Skinner, Ana Poveda-Gallego, John Rout, Iain Macleod, Saaeha Rauz, Simon Bowman, The TRACTISS Protocol: a randomised double blind placebo controlled clinical TRial of Anti-B-Cell Therapy In patients with primary Sjögren’s Syndrome, BMC Musculoskeletal Disorders, 2014, 15, 1, 21

    CrossRef

  10. 10
    Amy Donate, Alexandria Voigt, Cuong Q Nguyen, The value of animal models to study immunopathology of primary human Sjögren's syndrome symptoms, Expert Review of Clinical Immunology, 2014, 10, 4, 469

    CrossRef

  11. 11
    Crispian Scully, Scully's Medical Problems in Dentistry, 2014,

    CrossRef

  12. 12
    Érica Vieira Serrano, Valéria Valim, Samira Tatiyama Miyamoto, Raquel Altoé Giovelli, Maurício Aquino Paganotti, Nágela Valadão Cadê, Adaptação transcultural do “EULAR Sjögren's Syndrome Disease Activity Index (ESSDAI)” para a língua portuguesa, Revista Brasileira de Reumatologia, 2013, 53, 6, 483

    CrossRef

  13. 13
    ID O’Neill, C Scully, Biologics in oral medicine: Sjogren syndrome, Oral Diseases, 2013, 19, 2
  14. 14
    Divi Cornec, Sandrine Jousse-Joulin, Jacques-Olivier Pers, Thierry Marhadour, Béatrice Cochener, Sylvie Boisramé-Gastrin, Emmanuel Nowak, Pierre Youinou, Alain Saraux, Valérie Devauchelle-Pensec, Contribution of salivary gland ultrasonography to the diagnosis of Sjögren's syndrome: Toward new diagnostic criteria?, Arthritis & Rheumatism, 2013, 65, 1
  15. 15
    Yosra Thabet, Christelle Le Dantec, Ibtissem Ghedira, Valérie Devauchelle, Divi Cornec, Jacques-Olivier Pers, Yves Renaudineau, Epigenetic dysregulation in salivary glands from patients with primary Sjögren's syndrome may be ascribed to infiltrating B cells, Journal of Autoimmunity, 2013, 41, 175

    CrossRef

  16. 16
    Christelle Le Dantec, Alain Chevailler, Yves Renaudineau, Épigénétique et auto-immunité, Revue Francophone des Laboratoires, 2013, 2013, 457, 67

    CrossRef

  17. 17
    Haifeng Chen, Shiliang Zhou, Dinglei Su, Liwei Lu, Xia Li, Lingyun Sun, High-dose methylprednisolone pulse therapy upregulated FcγRIIb expression on B cells in primary Sjögren’s syndrome patients with thrombocytopenia, Clinical Rheumatology, 2013, 32, 12, 1783

    CrossRef

  18. 18
    C. Tarella, A. Gueli, M. Ruella, A. Cignetti, Lymphocyte transformation and autoimmune disorders, Autoimmunity Reviews, 2013, 12, 8, 802

    CrossRef

  19. 19
    Pilar Brito-Zerón, Antoni Sisó-Almirall, Albert Bové, Belchin A Kostov, Manuel Ramos-Casals, Primary Sjögren syndrome: an update on current pharmacotherapy options and future directions, Expert Opinion on Pharmacotherapy, 2013, 14, 3, 279

    CrossRef

  20. 20
    Christelle Dantec, Ruby Alonso, Tinhinane Fali, Enrique Montero, Valérie Devauchelle, Alain Saraux, Jacques-Olivier Pers, Yves Renaudineau, Rationale for treating primary Sjögren’s syndrome patients with an anti-CD6 monoclonal antibody (Itolizumab), Immunologic Research, 2013, 56, 2-3, 341

    CrossRef

  21. 21
    E. William St.Clair, Marc C. Levesque, Eline T. Luning Prak, Frederick B. Vivino, Chacko J. Alappatt, Meagan E. Spychala, Josiah Wedgwood, James McNamara, Kathy L. Moser Sivils, Lytia Fisher, Philip Cohen, Rituximab Therapy for Primary Sjögren's Syndrome: An Open-Label Clinical Trial and Mechanistic Analysis, Arthritis & Rheumatism, 2013, 65, 4
  22. 22
    Rada V. Moerman, Hendrika Bootsma, Frans G. M. Kroese, Arjan Vissink, Sjögren’s Syndrome in Older Patients, Drugs & Aging, 2013, 30, 3, 137

    CrossRef

  23. 23
    Divi Cornec, Alain Saraux, Valérie Devauchelle-Pensec, Coralie Clodic, Jacques-Olivier Pers, The future of B cell-targeted therapies in Sjögren’s syndrome, Immunotherapy, 2013, 5, 6, 639

    CrossRef

  24. 24
    Érica Vieira Serrano, Valéria Valim, Samira Tatiyama Miyamoto, Raquel Altoé Giovelli, Maurício Aquino Paganotti, Nágela Valadão Cadê, Transcultural adaptation of the “EULAR Sjögren's Syndrome Disease Activity Index (ESSDAI)” into Brazilian Portuguese, Revista Brasileira de Reumatologia (English Edition), 2013, 53, 6, 483

    CrossRef

  25. 25
    Sandrine Jousse-Joulin, Johanne Morvan, Valérie Devauchelle-Pensec, Alain Saraux, Ultrasound Assessment of the Entheses in Primary Sjögren Syndrome, Ultrasound in Medicine & Biology, 2013, 39, 12, 2485

    CrossRef

  26. 26
    Hendrika Bootsma, Hjalmar R. Bouma, Frans G.M. Kroese, Arjan Vissink, Daniel J. Wallace, Dubois' Lupus Erythematosus and Related Syndromes, 2013,

    CrossRef

  27. 27
    E. William St. Clair, Kelley's Textbook of Rheumatology, 2013,

    CrossRef

  28. 28
    Divi Cornec, Valérie Devauchelle-Pensec, Gabriel J. Tobón, Jacques-Olivier Pers, Sandrine Jousse-Joulin, Alain Saraux, B cells in Sjögren's syndrome: From pathophysiology to diagnosis and treatment, Journal of Autoimmunity, 2012, 39, 3, 161

    CrossRef

  29. 29
    Nishath Hamza, Nicolaas A. Bos, Cees G.M. Kallenberg, B-cell populations and sub-populations in Sjögren's syndrome, La Presse Médicale, 2012, 41, 9, e475

    CrossRef

  30. 30
    Simon Bowman, Francesca Barone, Biologic treatments in Sjögren's syndrome, La Presse Médicale, 2012, 41, 9, e495

    CrossRef

  31. 31
    Clio P Mavragani, Michael Voulgarelis, Haralampos M Moutsopoulos, Cytotoxics or biologicals in the treatment of Sjögren’s syndrome?, International Journal of Clinical Rheumatology, 2012, 7, 1, 63

    CrossRef

  32. 32
    Arjan Vissink, Hendrika Bootsma, Frans G.M. Kroese, Cees G.M. Kallenberg, How to assess treatment efficacy in Sjögrenʼs syndrome?, Current Opinion in Rheumatology, 2012, 24, 3, 281

    CrossRef

  33. 33
    Wayel H. Abdulahad, Frans G.M. Kroese, Arjan Vissink, Hendrika Bootsma, Immune regulation and B-cell depletion therapy in patients with primary Sjögren’s syndrome, Journal of Autoimmunity, 2012, 39, 1-2, 103

    CrossRef

  34. 34
    Raphaèle Seror, Hendrika Bootsma, Simon J. Bowman, Thomas Dörner, Jacques-Eric Gottenberg, Xavier Mariette, Manel Ramos-Casals, Philippe Ravaud, Elke Theander, Athanasios Tzioufas, Claudio Vitali, Outcome measures for primary Sjögren’s syndrome, Journal of Autoimmunity, 2012, 39, 1-2, 97

    CrossRef

  35. 35
    Christophe Jamin, Yves Renaudineau, Jacques-Olivier Pers, Pierre Youinou: When intuition and determination meet autoimmunity, Journal of Autoimmunity, 2012, 39, 3, 117

    CrossRef

  36. 36
    D. Cornec, J.-O. Pers, V. Devauchelle-Pensec, S. Jousse-Joulin, S. Varache, D. Guellec, T. Marhadour, P. Youinou, A. Saraux, Síndrome de Sjögren primario, EMC - Aparato Locomotor, 2012, 45, 4, 1

    CrossRef

  37. 37
    D. Cornec, J.-O. Pers, V. Devauchelle-Pensec, S. Jousse-Joulin, S. Varache, D. Guellec, T. Marhadour, P. Youinou, A. Saraux, Syndrome de Sjögren primitif, EMC - Appareil locomoteur, 2012, 7, 2, 1

    CrossRef

  38. 38
    Manuel Ramos-Casals, Pilar Brito-Zerón, Antoni Sisó-Almirall, Xavier Bosch, Athanasios G. Tzioufas, Topical and systemic medications for the treatment of primary Sjögren's syndrome, Nature Reviews Rheumatology, 2012, 8, 7, 399

    CrossRef

  39. 39
    Andreea Coca, Iñaki Sanz, Updates on B-cell immunotherapies for systemic lupus erythematosus and Sjogrenʼs syndrome, Current Opinion in Rheumatology, 2012, 1

    CrossRef

  40. 40
    Wan-Fai Ng, Simon J Bowman, Biological therapies in primary Sjögren's syndrome, Expert Opinion on Biological Therapy, 2011, 11, 7, 921

    CrossRef

  41. 41
    Pierre Youinou, Jacques-Olivier Pers, Disturbance of cytokine networks in Sjögren's syndrome, Arthritis Research & Therapy, 2011, 13, 4, 227

    CrossRef

  42. 42
    Morris A. Swartz, Frederick B. Vivino, Dramatic Reversal of Lymphocytic Interstitial Pneumonitis in Sjögren’s Syndrome With Rituximab, JCR: Journal of Clinical Rheumatology, 2011, 17, 8, 454

    CrossRef

  43. 43
    Barbara M. Segal, Abu N.M. Nazmul-Hossain, Ketan Patel, Pamela Hughes, Kathy L. Moser, Nelson L. Rhodus, Genetics and genomics of Sjögren's syndrome: research provides clues to pathogenesis and novel therapies, Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 2011, 111, 6, 673

    CrossRef

  44. 44
    GP Banninger, S Cha, MS Said, KM Pauley, CJ Carter, M Onate, BA Pauley, SM Anderson, ME Reyland, Loss of PKCδ results in characteristics of Sjögren’s syndrome including salivary gland dysfunction, Oral Diseases, 2011, 17, 6
  45. 45
    Ji-Young Kim, Sung-Hoon Park, Seong-Kyu Kim, Dae-Sung Hyun, Yoon Seup Kum, Kyung-Jae Jung, Jung-Yoon Choe, Lymphocytic Interstitial Pneumonia in Primary Sjögren's Syndrome: A Case Report, The Korean Journal of Internal Medicine, 2011, 26, 1, 108

    CrossRef

  46. 46
    Pierre-Yves Hatron, Isabelle Tillie-Leblond, David Launay, Eric Hachulla, Anne Laure Fauchais, Benoît Wallaert, Pulmonary manifestations of Sjögren's syndrome, La Presse Médicale, 2011, 40, 1, e71

    CrossRef

  47. 47
    Chung-Tei Chou, Recent developments in the diagnosis and management of Sjögren’s syndrome, International Journal of Clinical Rheumatology, 2011, 6, 4, 445

    CrossRef

  48. 48
    G. Le Guenno, M. Ruivard, L. Charra, P. Philippe, Rituximab-induced serum sickness in refractory immune thrombocytopenic purpura, Internal Medicine Journal, 2011, 41, 2
  49. 49
    Raphael Borie, Sophie Schneider, Marie-Pierre Debray, Homa Adle-Biasssette, Claire Danel, Anne Bergeron, Xavier Mariette, Michel Aubier, Thomas Papo, Bruno Crestani, Severe chronic bronchiolitis as the presenting feature of primary Sjögren’s syndrome, Respiratory Medicine, 2011, 105, 1, 130

    CrossRef

  50. 50
    Manuel Ramos-Casals, Cándido Díaz-Lagares, Munther A. Khamashta, Tratamiento depletivo de células B en enfermedades autoinmunitarias sistémicas. Recomendaciones de uso en la práctica clínica, Medicina Clínica, 2011, 136, 6, 257

    CrossRef

  51. 51
    Petra M Meiners, Arjan Vissink, Cees GM Kallenberg, Frans GM Kroese, Hendrika Bootsma, Treatment of primary Sjögren's syndrome with anti-CD20 therapy (rituximab). A feasible approach or just a starting point?, Expert Opinion on Biological Therapy, 2011, 11, 10, 1381

    CrossRef

  52. 52
    Esen Karamursel Akpek, Kristina B. Lindsley, Rohit S. Adyanthaya, Ramya Swamy, Alan N. Baer, Peter J. McDonnell, Treatment of Sjögren's Syndrome–Associated Dry Eye, Ophthalmology, 2011,

    CrossRef

  53. 53
    Gabriel J. Tobón, Jacques Olivier Pers, Pierre Youinou, Alain Saraux, B cell-targeted therapies in Sjögren's syndrome, Autoimmunity Reviews, 2010, 9, 4, 224

    CrossRef

  54. 54
    Marie-Michèle Varin, Laëtitia Le Pottier, Pierre Youinou, Damien Saulep, Fabienne Mackay, Jacques-Olivier Pers, B-cell tolerance breakdown in Sjögren's Syndrome: Focus on BAFF, Autoimmunity Reviews, 2010, 9, 9, 604

    CrossRef

  55. You have free access to this content55
    F. Perosa, M. Prete, V. Racanelli, F. Dammacco, CD20-depleting therapy in autoimmune diseases: from basic research to the clinic, Journal of Internal Medicine, 2010, 267, 3
  56. 56
    J. M. Meijer, P. M. Meiners, A. Vissink, F. K. L. Spijkervet, W. Abdulahad, N. Kamminga, E. Brouwer, C. G. M. Kallenberg, H. Bootsma, Effectiveness of rituximab treatment in primary Sjögren's syndrome: A randomized, double-blind, placebo-controlled trial, Arthritis & Rheumatism, 2010, 62, 4
  57. 57
    Dalila Mrabet, Nihel Meddeb, Héla Sahli, Faten Saadi, Elhem Chéour, Mohamed Elleuch, Slaheddine Sellami, Efficacité du rituximab dans une forme inhabituelle de syndrome de Sjögren primitif : à propos d’une observation, Thérapie, 2010, 65, 6, 581

    CrossRef

  58. 58
    Valérie Devauchelle-Pensec, Nicolas Cagnard, Jacques-Olivier Pers, Pierre Youinou, Alain Saraux, Gilles Chiocchia, Gene expression profile in the salivary glands of primary Sjögren's syndrome patients before and after treatment with rituximab, Arthritis & Rheumatism, 2010, 62, 8
  59. 59
    José Rosas Gómez de Salazar, José Miguel Senabre Gallego, Carlos Santos Ramírez, Manejo de las manifestaciones extraglandulares del síndrome de Sjögren primario, Reumatología Clínica, 2010, 6, 6

    CrossRef

  60. 60
    Anne-Marie Roguedas, Jacques-Olivier Pers, Gilles Lemasson, Valérie Devauchelle, Gabriel J. Tobón, Alain Saraux, Laurent Misery, Pierre Youinou, Memory B-cell aggregates in skin biopsy are diagnostic for primary Sjögren’s syndrome, Journal of Autoimmunity, 2010, 35, 3, 241

    CrossRef

  61. 61
    Xavier Mariette, Jacques-Eric Gottenberg, Pathogenesis of Sjögrenʼs syndrome and therapeutic consequences, Current Opinion in Rheumatology, 2010, 22, 5, 471

    CrossRef

  62. 62
    Shen Hu, Kai Gao, Rodney Pollard, Martha Arellano-Garcia, Hui Zhou, Lei Zhang, David Elashoff, Cees G. M. Kallenberg, Arjan Vissink, David T. Wong, Preclinical validation of salivary biomarkers for primary Sjögren's syndrome, Arthritis Care & Research, 2010, 62, 11
  63. 63
    W. F. Ng, S. J. Bowman, Primary Sjogren's syndrome: too dry and too tired, Rheumatology, 2010, 49, 5, 844

    CrossRef

  64. 64
    Ana Campar, David A. Isenberg, Primary Sjögren’s syndrome activity and damage indices comparison, European Journal of Clinical Investigation, 2010, 40, 7
  65. You have free access to this content65
    Suzanne L. Chapnick, Peter A. Merkel, Skin ulcers in a patient with Sjögren's syndrome, Arthritis Care & Research, 2010, 62, 7
  66. 66
    Thomas Dörner, Nils Kinnman, Paul P. Tak, Targeting B cells in immune-mediated inflammatory disease: A comprehensive review of mechanisms of action and identification of biomarkers, Pharmacology & Therapeutics, 2010, 125, 3, 464

    CrossRef

  67. 67
    Alain Saraux, The point on the ongoing B-cell depleting trials currently in progress over the world in primary Sjögren's syndrome, Autoimmunity Reviews, 2010, 9, 9, 609

    CrossRef

  68. 68
    Monica Fernández Castro, Lucía Silva, Teresa Otón, Jose Luis Andreu, Tratamiento de fondo del síndrome seco. ¿Qué puede aportar el reumatólogo?, Reumatología Clínica, 2010, 6, 1

    CrossRef

  69. 69
    Sandrine Jousse-Joulin, Essential Applications of Musculoskeletal Ultrasound in Rheumatology, 2010,

    CrossRef

  70. 70
    Hakan M. Gürcan, Derin B. Keskin, Joel N.H. Stern, Matthew A. Nitzberg, Haris Shekhani, A. Razzaque Ahmed, A review of the current use of rituximab in autoimmune diseases, International Immunopharmacology, 2009, 9, 1, 10

    CrossRef

  71. 71
    Angela Nagel, Michael Hertl, Rüdiger Eming, B-Cell-Directed Therapy for Inflammatory Skin Diseases, Journal of Investigative Dermatology, 2009, 129, 2, 289

    CrossRef

  72. 72
    D. Cornec, J. Avouac, P. Youinou, A. Saraux, Critical analysis of rituximab-induced serological changes in connective tissue diseases, Autoimmunity Reviews, 2009, 8, 6, 515

    CrossRef

  73. 73
    Thomas Dörner, David Isenberg, David Jayne, Heinz Wiendl, Detlef Zillikens, Gerd Burmester, Current status on B-cell depletion therapy in autoimmune diseases other than rheumatoid arthritis, Autoimmunity Reviews, 2009, 9, 2, 82

    CrossRef

  74. 74
    Susumu Sugai, Hiroki Takahashi, Shuji Ohta, Makoto Nishinarita, Masami Takei, Shigemasa Sawada, Ken Yamaji, Hiroshi Oka, Hisanori Umehara, Ichiro Koni, Eiji Sugiyama, Susumu Nishiyama, Atsushi Kawakami, Efficacy and safety of rebamipide for the treatment of dry mouth symptoms in patients with Sjögren’s syndrome: a double-blind placebo-controlled multicenter trial, Modern Rheumatology, 2009, 19, 2, 114

    CrossRef

  75. 75
    Susumu Sugai, Hiroki Takahashi, Shuji Ohta, Makoto Nishinarita, Masami Takei, Shigemasa Sawada, Ken Yamaji, Hiroshi Oka, Hisanori Umehara, Ichiro Koni, Eiji Sugiyama, Susumu Nishiyama, Atsushi Kawakami, Efficacy and safety of rebamipide for the treatment of dry mouth symptoms in patients with Sjögren’s syndrome: a double-blind placebo-controlled multicenter trial, Modern Rheumatology, 2009, 19, 2, 114

    CrossRef

  76. 76
    J. M. Meijer, P. M. Meiners, J. J. R. Huddleston Slater, F. K. L. Spijkervet, C. G. M. Kallenberg, A. Vissink, H. Bootsma, Health-related quality of life, employment and disability in patients with Sjogren's syndrome, Rheumatology, 2009, 48, 9, 1077

    CrossRef

  77. 77
    Jennifer H. Anolik, R. John Looney, Frances E. Lund, Troy D. Randall, Iñaki Sanz, Insights into the heterogeneity of human B cells: diverse functions, roles in autoimmunity, and use as therapeutic targets, Immunologic Research, 2009, 45, 2-3, 144

    CrossRef

  78. 78
    Laurent Arnaud, Julien Haroche, Jean-Charles Piette, Zahir Amoura, Les biothérapies immunomodulatrices du futur : quelles perspectives ?, La Presse Médicale, 2009, 38, 5, 749

    CrossRef

  79. 79
    Yves Renaudineau, Valérie Devauchelle-Pensec, Catherine Hanrotel, Jacques-Olivier Pers, Alain Saraux, Pierre Youinou, Mécanismes de l’action des anticorps monoclonaux anti-CD20 et surveillance biologique de leurs effets, Revue du Rhumatisme, 2009, 76, 9, 826

    CrossRef

  80. 80
    Yves Renaudineau, Valérie Devauchelle-Pensec, Catherine Hanrotel, Jacques-Olivier Pers, Alain Saraux, Pierre Youinou, Monoclonal anti-CD20 antibodies: Mechanisms of action and monitoring of biological effects, Joint Bone Spine, 2009, 76, 5, 458

    CrossRef

  81. 81
    J.-E. Gottenberg, Primary Sjögren's syndrome: Pathophysiological, clinical and therapeutic advances, Joint Bone Spine, 2009, 76, 6, 591

    CrossRef

  82. 82
    Vickie McDonald, Maria Leandro, Rituximab in non-haematological disorders of adults and its mode of action, British Journal of Haematology, 2009, 146, 3
  83. 83
    Damien Sène, Pascale Ghillani-Dalbin, Zahir Amoura, Lucile Musset, Patrice Cacoub, Rituximab may form a complex with iGmκ mixed cryoglobulin and induce severe systemic reactions in patients with hepatitis C virus–induced vasculitis, Arthritis & Rheumatism, 2009, 60, 12
  84. 84
    Cristina Alcântara, Maria João Gomes, Carlos Ferreira, Rituximab Therapy in Primary Sjögren's Syndrome, Annals of the New York Academy of Sciences, 2009, 1173, 1
  85. 85
    Roy M. Fleischmann, Safety of Biologic Therapy in Rheumatoid Arthritis and Other Autoimmune Diseases: Focus on Rituximab, Seminars in Arthritis and Rheumatism, 2009, 38, 4, 265

    CrossRef

  86. 86
    M. Morcillo Valle, Síndrome de Sjögren, Medicine - Programa de Formación Médica Continuada Acreditado, 2009, 10, 29, 1942

    CrossRef

  87. 87
    Jacques-Éric Gottenberg, Syndrome de Sjögren primitif : avancées physiopathologiques, cliniques et thérapeutiques, Revue du Rhumatisme, 2009, 76, 10-11, 944

    CrossRef

  88. 88
    M. C. Levesque, Translational Mini-Review Series on B Cell-Directed Therapies: Recent advances in B cell-directed biological therapies for autoimmune disorders, Clinical & Experimental Immunology, 2009, 157, 2
  89. 89
    K. Isaksen, R. Jonsson, R. Omdal, Anti-CD20 treatment in Primary Sjögren’s Syndrome, Scandinavian Journal of Immunology, 2008, 68, 6
  90. 90
    Marc C. Levesque, E. William St. Clair, B cell–directed therapies for autoimmune disease and correlates of disease response and relapse, Journal of Allergy and Clinical Immunology, 2008, 121, 1, 13

    CrossRef

  91. 91
    Jacques-Olivier Pers, Capucine Daridon, Boutahar Bendaoud, Valérie Devauchelle, Christian Berthou, Alain Saraux, Pierre Youinou, B-Cell Depletion and Repopulation in Autoimmune Diseases, Clinical Reviews in Allergy & Immunology, 2008, 34, 1, 50

    CrossRef

  92. 92
    Susumu Sugai, Yasafumi Masaki, Current and prospective treatment options for Sjögren’s syndrome, Expert Review of Clinical Immunology, 2008, 4, 4, 469

    CrossRef

  93. 93
    V. Devauchelle-Pensec, J.O. Pers, P. Youinou, A. Saraux, Le rituximab est-il un traitement d’avenir dans le syndrome de Sjögren ?, La Revue de Médecine Interne, 2008, 29, 12, 967

    CrossRef

  94. 94
    Pierre Youinou, Le syndrome de Gougerot-Sjögren : l’archétype des maladies auto-immunes induites par les cellules B, Revue du Rhumatisme, 2008, 75, 1, 3

    CrossRef

  95. 95
    J.-O. Pers, L. Le Pottier, V. Devauchelle, A. Saraux, P. Youinou, Les lymphocytes B dans le syndrome de Gougerot-Sjögren, La Revue de Médecine Interne, 2008, 29, 12, 1000

    CrossRef

  96. 96
    Carlos J Lozada, Robert W Hoffman, Management of mixed connective tissue disease, Future Rheumatology, 2008, 3, 4, 357

    CrossRef

  97. 97
    Nicolas Delaleu, Malin V. Jonsson, Silke Appel, Roland Jonsson, New Concepts in the Pathogenesis of Sjögren's Syndrome, Rheumatic Disease Clinics of North America, 2008, 34, 4, 833

    CrossRef

  98. 98
    Simon J. Bowman, Patient-Reported Outcomes Including Fatigue in Primary Sjögren's Syndrome, Rheumatic Disease Clinics of North America, 2008, 34, 4, 949

    CrossRef

  99. 99
    Hèctor Corominas, Ramon Fíguls, Manel Riera, Síndrome de Sjögren, Reumatología Clínica, 2008, 4, 22

    CrossRef

  100. 100
    Pierre Youinou, Sjögren's syndrome: A quintessential B cell-induced autoimmune disease, Joint Bone Spine, 2008, 75, 1, 1

    CrossRef

  101. 101
    D. G. Arkfeld, The potential utility of B cell-directed biologic therapy in autoimmune diseases, Rheumatology International, 2008, 28, 3, 205

    CrossRef

  102. 102
    Xavier Mariette, Therapeutic Potential for B-Cell Modulation in Sjögren's Syndrome, Rheumatic Disease Clinics of North America, 2008, 34, 4, 1025

    CrossRef

  103. 103
    Jacques-Éric Gottenberg, Xavier Mariette, Actualités sur la physiopathologie du syndrome de Gougerot-Sjögren, Revue du Rhumatisme, 2007, 74, 8, 732

    CrossRef

  104. 104
    Jacques-Olivier Pers, Valérie Devauchelle, Capucine Daridon, Boutahar Bendaoud, Rozenn Le Berre, Anne Bordron, Pascal Hutin, Yves Renaudineau, Maryvonne Dueymes, Séverine Loisel, Christian Berthou, Alain Saraux, Pierre Youinou, BAFF-modulated repopulation of B lymphocytes in the blood and salivary glands of RITUXIMAB-TREATED patients with Sjögren's syndrome, Arthritis & Rheumatism, 2007, 56, 5
  105. 105
    Marcella Visentini, Massimo Granata, Maria Luisa Veneziano, Federica Borghese, Maurizio Carlesimo, Fulvia Pimpinelli, Massimo Fiorilli, Milvia Casato, Efficacy of low-dose rituximab for mixed cryoglobulinemia, Clinical Immunology, 2007, 125, 1, 30

    CrossRef

  106. 106
    P. Disperati, L. K. Hicks, R. Buckstein, Rituximab-induced serum sickness in a patient with follicular lymphoma, Leukemia & Lymphoma, 2007, 48, 8, 1633

    CrossRef